Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer.
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.
Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer.
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility. Oncogene. 1999 Jan 07; 18(1):67-77.
View in:
PubMed
subject areas
3T3 Cells
Animals
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell
Cell Adhesion Molecules
Cell Movement
Cytoskeletal Proteins
Gene Expression
Humans
Lung Neoplasms
Mice
Paxillin
Phosphoproteins
Recombinant Fusion Proteins
Tumor Cells, Cultured
authors with profiles
Ravi Salgia